H-MLAVISCAV-OH

Ref. 3D-PP48261

Información del producto

• Nombre: H-MLAVISCAV-OH

Descripción

Peptide H-MLAVISCAV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-MLAVISCAV-OH include the following: Uncovering the tumor antigen landscape: what to know about the discovery process S Feola, J Chiaro , B Martins, V Cerullo - Cancers, 2020 - mdpi.comhttps://www.mdpi.com/2072-6694/12/6/1660 Immunotherapy for malignant melanoma-tracing Ariadne's thread through the labyrinth JM Grange, B Krone, JL Stanford - European Journal of Cancer, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804909003426 Evolutionary aspects of human endogenous retroviral sequences (HERVs) and disease J Blomberg , D Ushameckis, P Jern - Madame Curie Bioscience , 2013 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/books/NBK6235/ A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes F Schiavetti, J Thonnard, D Colau, T Boon, PG Coulie - Cancer research, 2002 - AACRhttps://aacrjournals.org/cancerres/article-abstract/62/19/5510/509172 Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk B Krone, KF Kölmel, BM Henz, JM Grange - European Journal of Cancer, 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0959804904006756 Human endogenous retroviruses and their implication for immunotherapeutics of cancer AS Attermann, AM Bjerregaard , SK Saini , K GronbacaŠk - Annals of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0923753419318915 Studio epidemiologico sull'effetto protettivo contro il melanoma del vaccino anti febbre gialla A Buja - 2008 - research.unipd.ithttps://www.research.unipd.it/handle/11577/3425202

• Marca: Biosynth